Literature DB >> 28806176

Evaluating the Use of Ketamine for Pain Control With Sickle Cell Crisis in Pregnancy: A Report of 2 Cases.

Alexis C Gimovsky, Kate Fritton, Eugene Viscusi, Amanda Roman.   

Abstract

Sickle cell crises occur frequently during pregnancy and are difficult to treat, even with high-dose opioids. Analgesia with ketamine has been suggested as an alternative, but its use during pregnancy is underreported. Two pregnant patients with uncontrolled sickle cell pain were treated with ketamine. Patient A reported no decrease in her pain, but her opioid requirements decreased. Patient B's pain resolved during ketamine administration. No serious maternal or neonatal adverse effects occurred. Ketamine may be considered as an adjunct analgesic in pregnant patients with sickle cell pain, although prospective clinical data are needed to fully assess its efficacy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28806176     DOI: 10.1213/XAA.0000000000000624

Source DB:  PubMed          Journal:  A A Pract        ISSN: 2575-3126


  7 in total

1.  American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Authors:  Amanda M Brandow; C Patrick Carroll; Susan Creary; Ronisha Edwards-Elliott; Jeffrey Glassberg; Robert W Hurley; Abdullah Kutlar; Mohamed Seisa; Jennifer Stinson; John J Strouse; Fouza Yusuf; William Zempsky; Eddy Lang
Journal:  Blood Adv       Date:  2020-06-23

2.  Subdissociative-dose ketamine for sickle cell vaso-occlusive crisis: a narrative review for the emergency physician.

Authors:  Mohammad H Bawany; Sergey M Motov
Journal:  Clin Exp Emerg Med       Date:  2022-09-30

3.  Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease.

Authors:  Mohammed S Alshahrani; Laila Perlas Asonto; Mohamed M El Tahan; Amal H Al Sulaibikh; Sukayna Z Al Faraj; Abdullah A Al Mulhim; Murad F Al Abbad; Samar A Al Nahhash; Moath N Aldarweesh; Alaa M Mahmoud; Nisreen Almaghraby; Mohammed A Al Jumaan; Thamir O Al Junaid; Faisal M Al Hawaj; Samar AlKenany; Omaima F ElSayed; Haitham M Abdelwahab; Mohamed M Moussa; Bader K Alossaimi; Shaikah K Alotaibi; Talal M AlMutairi; Duaa A AlSulaiman; Saad D Al Shahrani; Donia Alfaraj; Waleed Alhazzani
Journal:  Trials       Date:  2019-05-27       Impact factor: 2.279

Review 4.  Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review.

Authors:  Mohammed S Alshahrani; Mohannad A Alghamdi
Journal:  Saudi J Med Med Sci       Date:  2020-12-26

5.  The effect of ketamine on preventing postpartum depression.

Authors:  Mina Alipoor; Marzeyeh Loripoor; Majid Kazemi; Farshid Farahbakhsh; Ali Sarkoohi
Journal:  J Med Life       Date:  2021 Jan-Mar

Review 6.  Moving Toward a Multimodal Analgesic Regimen for Acute Sickle Cell Pain with Non-Opioid Analgesic Adjuncts: A Narrative Review.

Authors:  Martha O Kenney; Wally R Smith
Journal:  J Pain Res       Date:  2022-03-31       Impact factor: 3.133

Review 7.  Neurocritical Care of the Pregnant Patient.

Authors:  Deepa Malaiyandi; Elysia James; Lindsay Peglar; Nurose Karim; Nicholas Henkel; Kristin Guilliams
Journal:  Curr Treat Options Neurol       Date:  2021-06-21       Impact factor: 3.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.